Latest & greatest articles for pregnancy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pregnancy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pregnancy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pregnancy

1. COVID-19 in pregnant women: A systematic review and meta-analysis Full Text available with Trip Pro

studies are needed to better elucidate the role of SARS-CoV-2 during pregnancy. Keywords: COVID-19; Neonate; Pregnancy; SARS-CoV-2; Vertical transmission. Copyright © 2020 Elsevier B.V. All rights reserved. Conflict of interest statement Declaration of Competing Interest The Authors state that they do not have any conflict of interest Figures Fig. 1 5 PRISMA 2009 Flow Diagram. Fig. 1 13 PRISMA 2009 Flow Diagram. Fig. 1 PRISMA 2009 Flow Diagram. Fig. 2 5 Fever at admission in pregnant… Fig. 2 13 Fever (...) COVID-19 in pregnant women: A systematic review and meta-analysis COVID-19 in pregnant women: A systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information from CDC: . Get the latest research from NIH: . Find NCBI

2020 EvidenceUpdates

2. Is there an increased risk of adverse maternal or fetal outcomes in women diagnosed with COVID-19 during pregnancy?

included 4 RT-PCR positive neonates, 2 stillbirths, and 1 neonatal death. No evidence of vertical transmission. Limited data suggest that pregnant women have a clinical presentation and severity similar to non- pregnant adults, and adverse maternal and perinatal outcomes were rare. Low Not reported Yang Z, Wang M, Zhu Z, & Liu Y. (2020). Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review J Matern Fetal Neonatal Med. Epub ahead of print. Apr 20, 2020 (Search to Mar 26, 2020 (...) . No direct evidence of intrauterine vertical transmission. Moderate Low Version 1: May 15, 2020 7 The clinical characteristics of pregnant women with COVID-19 are similar to those of non-pregnant adults. Fetal and neonatal outcomes appear good in most cases. Limitation: Available data only include pregnant women infected in their third trimesters. Della Gatta AN, Rizzo R, Pilu G, & Simonazzi G. (2020). COVID19 during pregnancy: a systematic review of reported cases Am J Obstet Gynecol. Epub ahead

2020 COVID-19 Rapid Evidence Service

3. What is the efficacy of fosfomycin for uncomplicated cystitis in non-pregnant women?

What is the efficacy of fosfomycin for uncomplicated cystitis in non-pregnant women? July 27, 2020 Burning Evidence for Fosfomycin in Cystitis Clinical Question: What is the efficacy of fosfomycin for uncomplicated cystitis in non-pregnant women? Bottom Line: At best, single dose fosfomycin has similar efficacy to other antibiotics for uncomplicated cystitis. However, the best quality, publicly funded trial showed it was not as efficacious as nitrofurantoin, with 58% of cases clinically

2020 Tools for Practice

4. Coronavirus (COVID-19) infection and pregnancy

with or for COVID-19. 15 Similar findings were reported in a large systematic review of 2,567 pregnancies with COVID-19, where 50.8% of women were from a BAME background. 38.2% of the women were obese and 32.5% had chronic comorbidities such as asthma and hypertension. 28 The association with BAME is particularly apparent and echoes previous findings that UK BAME pregnant women generally have worse outcomes in pregnancy and birth. 23 Furthermore, 13% of the UK’s total population identifies as being from a BAME (...) affects 5% of pregnant women in the UK, with the majority (88%) of women with diabetes in pregnancy affected by gestational diabetes. 39 In the UKOSS study, comorbidities such as diabetes were associated with pregnant women being admitted to hospital with COVID-19. 15 In non-pregnant individuals, a UK study of 20,133 patients admitted to high dependency and intensive care with COVID-19 found uncomplicated diabetes was one of the most common comorbidities (21%, 3650/17599); a further 7% (n=1299

2020 Royal College of Obstetricians and Gynaecologists

5. Nutritional interventions update: multiple micronutrient supplements during pregnancy

Agency for International Development WHO World Health OrganizationExecutive summary vii Executive summary Introduction The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was published in 2016 with the objective of improving the quality of routine health care that all women and adolescent girls receive during pregnancy. The overarching principle – to provide pregnant service users with a positive (...) ). The GDG experts also provided additional remarks where they considered them necessary. Users of the guideline should refer to these remarks, as well as to the evidence summary, for further information about the basis of this WHO recommendation. The updated WHO recommendation on antenatal MMS for a positive pregnancy experience This recommendation applies to pregnant women and adolescent girls within the context of routine ANC. WHO recommendation on antenatal multiple micronutrient supplements (MMS

2020 World Health Organisation Guidelines

6. Nutritional interventions update: vitamin D supplements during pregnancy

Health OrganizationExecutive summary vii Executive summary Introduction The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was first published in 2016 with the objective of improving the quality of routine health care that all women and adolescent girls receive during pregnancy. The overarching principle – to provide pregnant service users with a positive pregnancy experience – aims to encourage (...) summary, for further information about the basis of this WHO recommendation. The updated WHO recommendation on antenatal oral vitamin D supplements for a positive pregnancy experience This recommendation applies to pregnant women and adolescent girls within the context of routine ANC. WHO recommendation on antenatal oral vitamin D supplements Oral vitamin D supplementation is not recommended for all pregnant women to improve maternal and perinatal outcomes. (Not recommended) Remarks

2020 World Health Organisation Guidelines

7. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Pregnancy and the Possibility of Vertical Transmission

' test results for COVID-19 infection were positive in this review. Keywords: Coronavirus Disease 2019 (COVID-19); Neonatal outcomes; Pregnancy; Pregnant women; SARS-CoV-2; Systematic review; Vertical transmission. Copyright© 2020, Avicenna Research Institute. Conflict of interest statement Conflict of Interest Non-declared. Funding: There is no funding resource for this study. Figures Figure 1. 5 Flow diagram of study selection… Figure 1. 13 Flow diagram of study selection process Figure 1. Flow (...) Coronavirus Disease 2019 (COVID-19): A Systematic Review of Pregnancy and the Possibility of Vertical Transmission Coronavirus Disease 2019 (COVID-19): A Systematic Review of Pregnancy and the Possibility of Vertical Transmission - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation

2020 EvidenceUpdates

8. Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial Full Text available with Trip Pro

Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging (...) ? Report format: Send at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation JAMA Netw Open Actions . 2020 Jun 1;3(6):e205323. doi: 10.1001/jamanetworkopen.2020.5323. Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth

2020 EvidenceUpdates

9. Clinical Presentation and Outcomes of Pregnant Women with COVID-19: A Systematic Review and Meta-Analysis Full Text available with Trip Pro

disease-2019 (COVID-19) have focused on the non-pregnant adult population. This study aims to describe the clinical characteristics and perinatal outcomes of COVID-19 in pregnancy. Methods: We searched databases from December 2019 to April 30th, 2020. Eligible studies reported clinical characteristics, radiological findings and/or laboratory testing of pregnant women during infection. Data were pooled across studies using random-effects model. Results: Twenty-four studies (136 women) were included (...) Clinical Presentation and Outcomes of Pregnant Women with COVID-19: A Systematic Review and Meta-Analysis Clinical Presentation and Outcomes of Pregnant Women with COVID-19: A Systematic Review and Meta-Analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest

2020 EvidenceUpdates

10. Coronavirus (COVID-19) infection and pregnancy

professionals based on a combination of available evidence, good practice and expert consensus opinion. The priorities are: (i) The reduction of transmission of COVID-19 to pregnant women. (ii) The provision of safe, personalised and woman-centred care during pregnancy, birth and the early postnatal period during the COVID-19 pandemic. (iii) The provision of safe, personalised and woman-centred care to pregnant and postnatal women with suspected/confirmed COVID-19. Please be aware that this is very much (...) . We will update the RCOG guidance if these change. 1.3 Transmission Most global cases of COVID-19 have evidence of human-to-human transmission. This virus can be readily isolated from respiratory secretions, faeces and fomites (objects). Transmission of the virus is known to occur through close contact with an infected person (within 2 metres) or from contaminated surfaces. Pregnant women do not appear more likely to contract the infection than the general population. 5 6 Pregnancy itself alters

2020 Royal College of Obstetricians and Gynaecologists

11. Infectious diseases in pregnancy screening (IDPS): programme overview

Infectious diseases in pregnancy screening (IDPS): programme overview Infectious diseases in pregnancy screening (IDPS): programme overview - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Infectious diseases in pregnancy screening (IDPS): programme overview (...) Information on the programme, including the screening tests, commissioning, quality assurance, education and training. Published 1 January 2015 Last updated 23 June 2020 — From: Contents Public information about . Healthcare professionals, including midwives should offer and recommend screening to all pregnant women as part of their antenatal care. Screening is a choice, however the early detection and treatment offered by screening can significantly reduce the chances of a mother passing on an infection

2020 Public Health England

12. Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT Full Text available with Trip Pro

Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata

2020 NIHR HTA programme

13. Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection: A Systematic Review Full Text available with Trip Pro

Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection: A Systematic Review Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection: A Systematic Review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set (...) text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Obstet Gynecol Actions . 2020 Jun 9. doi: 10.1097/AOG.0000000000004010. Online ahead of print. Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2

2020 EvidenceUpdates

14. Pregnancy and COVID-19: a systematic review of maternal, obstetric and neonatal outcomes Full Text available with Trip Pro

Pregnancy and COVID-19: a systematic review of maternal, obstetric and neonatal outcomes Pregnancy and COVID-19: a systematic review of maternal, obstetric and neonatal outcomes - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology Information (...) Cite Share Permalink Copy Page navigation J Matern Fetal Neonatal Med Actions . 2020 Jul 7;1-13. doi: 10.1080/14767058.2020.1781809. Online ahead of print. Pregnancy and COVID-19: a systematic review of maternal, obstetric and neonatal outcomes , , , , Affiliations Expand Affiliations 1 Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. 2 ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal. 3 Department of Obstetrics

2020 EvidenceUpdates

15. Effects of COVID-19 Infection during Pregnancy and Neonatal Prognosis: What Is the Evidence? Full Text available with Trip Pro

Abstract Background: This study's aims are to assess the current evidence presented in the literature regarding the potential risks of COVID-19 infection among pregnant women and consequent fetal transmission. Methods: a systematic literature review assessing papers published in the most comprehensive databases in the field of health intended to answer the question, "What are the effects of COVID-19 infection during pregnancy, and what is the neonatal prognosis?" Results: 49 papers published in 2020 (...) Effects of COVID-19 Infection during Pregnancy and Neonatal Prognosis: What Is the Evidence? Effects of COVID-19 Infection during Pregnancy and Neonatal Prognosis: What Is the Evidence? - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology

2020 EvidenceUpdates

16. COVID-19 in Pregnant Women and Neonates: A Systematic Review of the Literature with Quality Assessment of the Studies Full Text available with Trip Pro

were admitted in the ICU, and one died. Two stillbirths were reported and the incidence of prematurity was 28%. Sixteen neonates were tested positive for SARS-CoV-2 by RT-PCR, and nine of them were born from mothers infected during pregnancy. Neonatal outcomes were generally good: all the affected neonates recovered. RT-PCR for SARS-CoV-2 yielded negative results on amniotic fluid, vaginal/cervical fluids, placenta tissue, and breast milk samples. SARS-CoV-2 infection in pregnant women appeared (...) COVID-19 in Pregnant Women and Neonates: A Systematic Review of the Literature with Quality Assessment of the Studies COVID-19 in Pregnant Women and Neonates: A Systematic Review of the Literature with Quality Assessment of the Studies - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library

2020 EvidenceUpdates

17. Prescription of macrolides vs penicillin during pregnancy was linked to major malformations in offspring. (Abstract)

Prescription of macrolides vs penicillin during pregnancy was linked to major malformations in offspring. Fan H, Gilbert R, O'Callaghan F, Li L. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study. BMJ. 2020;368:m331. 32075790.

2020 Annals of Internal Medicine

18. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. Full Text available with Trip Pro

in pregnancy was 4.9 (95% confidence interval 4.5 to 5.4) per 1000 maternities. 233 (56%) pregnant women admitted to hospital with SARS-CoV-2 infection in pregnancy were from black or other ethnic minority groups, 281 (69%) were overweight or obese, 175 (41%) were aged 35 or over, and 145 (34%) had pre-existing comorbidities. 266 (62%) women gave birth or had a pregnancy loss; 196 (73%) gave birth at term. Forty one (10%) women admitted to hospital needed respiratory support, and five (1%) women died (...) . Twelve (5%) of 265 infants tested positive for SARS-CoV-2 RNA, six of them within the first 12 hours after birth.Most pregnant women admitted to hospital with SARS-CoV-2 infection were in the late second or third trimester, supporting guidance for continued social distancing measures in later pregnancy. Most had good outcomes, and transmission of SARS-CoV-2 to infants was uncommon. The high proportion of women from black or minority ethnic groups admitted with infection needs urgent investigation

2020 BMJ

19. Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association Full Text available with Trip Pro

, and significant aortic dilatation with underlying connective tissue disease. Women with these conditions are often advised to avoid pregnancy. However, it is not uncommon for women to present pregnant, and at that point, the high-risk cardio-obstetrics team must work together to come up with the best way to mitigate maternal cardiovascular and obstetric risk and fetal risk moving forward. Medical Conditions During Pregnancy Hypertensive Disorders in Pregnancy Hypertensive disorders of pregnancy (HDP (...) treatment before pregnancy. Current treatment options for pregnant women with familial hypercholesterolemia include bile acid sequestrants, which lack systemic circulation, and, as last resort, low-density lipoprotein apheresis in severe cases ( ). , Ischemic Heart Disease in Pregnancy Ischemic heart disease during pregnancy constitutes a rare but potentially fatal condition. The risk of acute myocardial infarction (MI) is 3- to 4-fold higher in pregnant women compared with their nonpregnant

2020 American Heart Association

20. Management of Genital Herpes in Pregnancy

Management of Genital Herpes in Pregnancy Management of Genital Herpes in Pregnancy | ACOG Clinical Guidance Journals & Publications Patient Education Topics Featured Clinical Topics Hi, Featured Clinical Topics Clinical Guidance Management of Genital Herpes in Pregnancy Practice Bulletin Number 220 May 2020 Jump to Resources Share By reading this page you agree to ACOG's Terms and Conditions. . Because many women of childbearing age are infected or will be infected with HSV, the risk (...) of maternal transmission of this virus to the fetus or newborn is a major health concern. This document has been revised to include that for women with a primary or nonprimary first-episode genital HSV infection during the third trimester of pregnancy, cesarean delivery may be offered due to the possibility of prolonged viral shedding. Log in to read more This content is only available to members and subscribers. Nonmembers: Subscribe now to access exclusive ACOG Clinical content, including: ACOG Clinical

2020 American College of Obstetricians and Gynecologists